Company / Income Tax
Fulgent Genetics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$8.4M
FY2025
5-year range
-$8.4M / $174.8M
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
#154 of 162
Health Care
What the data says
Among 162 Health Care companies, Fulgent Genetics, Inc. is in the top 5% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$8M in FY2025 to $175M in FY2023.
Based on SEC 10-K filings.
-$8M in FY2025.
Improved from $175M to -$8M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 162This company -$8.4M Sector average $145.4M
▼
-105.8% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 3.2% year-over-year.
- Ranks #154 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.4M | -3.2% |
| FY2024 | -$8.1M | -104.7% |
| FY2023 | $174.8M | +141.0% |
| FY2022 | $72.5M | +168579.1% |
| FY2021 | $43.0K | -99.9% |
| FY2020 | $72.5M | +201377.8% |
| FY2019 | $36.0K | +103.5% |
| FY2018 | -$1.0M | +0.0% |
| FY2017 | -$1.0M | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026